Advertisement
Original Investigation|Articles in Press

Diffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat Saturation

Published:February 08, 2023DOI:https://doi.org/10.1016/j.acra.2023.01.014

      Rationale and Objectives

      In breast MRI with diffusion-weighted imaging (DWI), fat suppression is essential for eliminating the dominant lipid signal. This investigation evaluates a combined water-excitation-spectral-fatsat method (WEXfs) versus standard spectral attenuated inversion recovery (SPAIR) in high-resolution 3-Tesla breast MRI.

      Materials and Methods

      Multiparametric breast MRI with 2 echo-planar DWI sequences was performed in 83 patients (50.1 ± 12.6 years) employing either WEXfs or SPAIR for fat signal suppression. Three radiologists assessed overall DWI quality and delineability of 88 focal lesions (28 malignant, 60 benign) on images with b values of 800 and 1600 s/mm2, as well as apparent diffusion coefficient (ADC) maps. For each fat suppression method and b value, the longest lesion diameter was determined in addition to measuring the signal intensity in DWI and ADC value in standardized regions of interest.

      Results

      Regardless of b values, image quality (all p < 0.001) and lesion delineability (all p ≤ 0.003) with WEXfs-DWI were deemed superior compared to SPAIR-DWI in benign and malignant lesions. Irrespective of lesion characterization, WEXfs-DWI provided superior signal-to-noise, contrast-to-noise and signal-intensity ratios with 1600 s/mm2 (all p ≤ 0.05). The lesion size difference between contrast-enhanced T1 subtraction images and DWI was smaller for WEXfs compared to SPAIR fat suppression (all p ≤ 0.007). The mean ADC value in malignant lesions was lower for WEXfs-DWI (p < 0.001), while no significant ADC difference was ascertained between both techniques in benign lesions (p = 0.947).

      Conclusion

      WEXfs-DWI provides better subjective and objective image quality than standard SPAIR-DWI, resulting in a more accurate estimation of benign and malignant lesion size.

      Key Words

      Abbreviations:

      ADC (apparent diffusion coefficient), CNR (contrast-to-noise ratio), DCE (dynamic contrast enhanced), DWI (diffusion-weighted imaging), ROI (region of interest), SD (standard deviation), SI (signal intensity), SIR (signal-intensity ratio), SNR (signal-to-noise ratio), SPAIR (spectral attenuated inversion recovery), WEXfs (water-excitation-spectral-fatsat combination)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mann RM
        • Cho N
        • Moy L.
        Breast MRI: state of the art.
        Radiology. 2019; 292: 520-536
        • Kuhl C
        • Weigel S
        • Schrading S
        • et al.
        Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: The EVA trial.
        J Clin Oncol. 2010; 28: 1450-1457
        • Mann RM
        • Kuhl CK
        • Kinkel K
        • Boetes C.
        • Breast MRI
        Guidelines from the European Society of Breast Imaging.
        Eur Radiol. 2008; 18: 1307-1318
        • Riedl CC
        • Luft N
        • Bernhart C
        • et al.
        Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
        J Clin Oncol. 2015; 33: 1128
        • Bick U
        • Engel C
        • Krug B
        • et al.
        High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
        Breast Cancer Res Treat. 2019; 175: 217-228
        • Sardanelli F
        • Podo F
        • Santoro F
        • et al.
        Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (The High Breast Cancer Risk Italian 1 Study).
        Invest Radiol. 2011 Feb; 46: 94-105
        • Mann RM
        • Kuhl CK
        • Moy L.
        Contrast-enhanced MRI for breast cancer screening.
        J Magn Reson Imaging. 2019; 50: 377-390
        • Mann RM
        • Athanasiou A
        • Baltzer PAT
        • et al.
        Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI).
        Eur Radiol. 2022; 32: 4036-4045
        • McDonald RJ
        • McDonald JS
        • Kallmes DF
        • et al.
        Intracranial gadolinium deposition after contrast-enhanced MR imaging.
        Radiology. 2015; 275: 772-782
        • Gulani V
        • Calamante F
        • Shellock FG
        • Kanal E
        • Reeder SB.
        Gadolinium deposition in the brain: summary of evidence and recommendations.
        Lancet Neurol. 2017; 16: 564-570
        • Kim JJ
        • Kim JY.
        Fusion of high b-value diffusion-weighted and unenhanced T1-weighted images to diagnose invasive breast cancer: factors associated with false-negative results.
        Eur Radiol. 2021; 31: 4860-4871
        • Pinker K
        • Moy L
        • Sutton EJ
        • et al.
        Diffusion-weighted imaging with apparent diffusion coefficient mapping for breast cancer detection as a stand-alone parameter: comparison with dynamic contrast-enhanced and multiparametric magnetic resonance imaging.
        Invest Radiol. 2018; 53: 587-595
        • Baltzer PAT
        • Bickel H
        • Spick C
        • et al.
        Potential of noncontrast magnetic resonance imaging with diffusion-weighted imaging in characterization of breast lesions: intraindividual comparison with dynamic contrast-enhanced magnetic resonance imaging.
        Invest Radiol. 2018; 53: 229-235
        • le Bihan D
        • Iima M.
        Diffusion magnetic resonance imaging: what water tells us about biological tissues.
        PLoS Biol. 2015; 13e1002203
        • Koh DM
        • Collins DJ.
        Diffusion-weighted MRI in the body: applications and challenges in oncology.
        AJR Am J Roentgenol. 2007; 188: 1622-1635
        • Nogueira L
        • Brandão S
        • Matos E
        • et al.
        Diffusion-weighted imaging: determination of the best pair of b-values to discriminate breast lesions.
        Br J Radiol. 2014; 8720130807
        • Baltzer P
        • Mann RM
        • Iima M
        • et al.
        Diffusion-weighted imaging of the breast—a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group.
        Eur Radiol. 2020; 30: 1436-1450
        • Bickel H
        • Polanec SH
        • Wengert G
        • et al.
        Diffusion-weighted MRI of breast cancer: improved lesion visibility and image quality using synthetic b-values.
        J Magn Reson Imaging. 2019; 50: 1754-1761
        • Ohlmeyer S
        • Laun FB
        • Bickelhaupt S
        • et al.
        Ultra-High b-value diffusion-weighted imaging-based abbreviated protocols for breast cancer detection.
        Invest Radiol. 2021; 56: 629-636
        • Wenkel E
        • Geppert C
        • Schulz-Wendtland R
        • et al.
        Diffusion weighted imaging in breast MRI. Comparison of two different pulse sequences.
        Acad Radiol. 2007; 14: 1077-1083
        • Chebrolu VV
        • Frick M
        • Kollasch P
        • et al.
        Fat saturation in musculoskeletal MRI using Spectral Heterogeneity Adaptive RF Pulses (SHARP).
        in: ISMRM Annual Meeting Proceedings. 2018
        • Bley TA
        • Wieben O
        • François CJ
        • Brittain JH
        • Reeder SB.
        Fat and water magnetic resonance imaging.
        J Magn Reson Imaging. 2010; 31: 4-18
        • del Grande F
        • Santini F
        • Herzka DA
        • et al.
        Fat-suppression techniques for 3-T MR imaging of the musculoskeletal system.
        Radiographics. 2014; 34: 217-233
        • Bae SH
        • Hwang J
        • Hong SS
        • et al.
        Clinical feasibility of accelerated diffusion weighted imaging of the abdomen with deep learning reconstruction: comparison with conventional diffusion weighted imaging.
        Eur J Radiol. 2022; 154110428
        • Breast Imaging Working Group of the German Radiological Society
        Updated recommendations for MRI of the breast.
        Rofo. 2014; 186: 482-483
        • Park JH
        • la Yun B
        • Jang M
        • et al.
        Comparison of the diagnostic performance of synthetic versus acquired high b-Value (1500 s/mm2) diffusion-weighted MRI in women with breast cancers.
        J Magn Reson Imaging. 2019; 49: 857-863
        • Partridge SC
        • McDonald ES.
        Diffusion weighted magnetic resonance imaging of the breast.
        Magn Reson Imaging Clin N Am. 2013; 21: 601-624
        • Daimiel Naranjo I
        • lo Gullo R
        • Saccarelli C
        • et al.
        Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
        Eur Radiol. 2021; 31: 356-367
        • Zhu H
        • Arlinghaus LR
        • Whisenant JG
        • Li M
        • Gore JC
        • Yankeelov TE.
        Sequence design and evaluation of the reproducibility of water selective diffusion weighted imaging of the breast at 3T.
        NMR Biomed. 2014; 27: 1030
        • Kul S
        • Metin Y
        • Kul M
        • Metin N
        • Eyuboglu I
        • Ozdemir O.
        Assessment of breast mass morphology with diffusion-weighted MRI: beyond apparent diffusion coefficient.
        J Magn Reson Imaging. 2018; 48: 1668-1677
        • Radovic N
        • Ivanac G
        • Divjak E
        • Biondic I
        • Bulum A
        • Brkljacic B.
        Evaluation of breast cancer morphology using diffusion-weighted and dynamic contrast-enhanced MRI: intermethod and interobserver agreement.
        J Magn Reson Imaging. 2019; 49: 1381-1390
        • Baron P
        • Dorrius MD
        • Kappert P
        • Oudkerk M
        • Sijens PE.
        Diffusion-weighted imaging of normal fibroglandular breast tissue: influence of microperfusion and fat suppression technique on the apparent diffusion coefficient.
        NMR Biomed. 2010; 23: 399-405
        • Jones DK
        • Cercignani M.
        Twenty-five pitfalls in the analysis of diffusion MRI data.
        NMR Biomed. 2010; 23: 803-820
        • Giannelli M
        • Sghedoni R
        • Iacconi C
        • et al.
        MR scanner systems should be adequately characterized in diffusion-MRI of the breast.
        PLoS One. 2014; 9: e86280
        • le Bihan D
        • Poupon C
        • Amadon A
        • Lethimonnier F.
        Artifacts and pitfalls in diffusion MRI.
        J Magn Reson Imaging. 2006; 24: 478-488
        • Bae SJ
        • Ahn SG
        • Yoon CI
        • et al.
        Measuring tumor extent based on subtypes using magnetic resonance imaging: radiologic-pathologic discordance and high positive margin rates in breast cancer.
        J Breast Cancer. 2019; 22: 453
        • Yoo EY
        • Nam SY
        • Choi HY
        • Hong MJ.
        Agreement between MRI and pathologic analyses for determination of tumor size and correlation with immunohistochemical factors of invasive breast carcinoma.
        Acta Radiol. 2018; 59: 50-57
        • Lee EJ
        • Chang YW
        • Sung JK
        • Thomas B.
        Feasibility of deep learning k-space-to-image reconstruction for diffusion weighted imaging in patients with breast cancers: focus on image quality and reduced scan time.
        Eur J Radiol. 2022; 157110608